Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

Cited In for PubMed (Select 16051820)

1.

Benzothiazole and Pyrrolone Flavivirus Inhibitors Targeting the Viral Helicase.

Sweeney NL, Hanson AM, Mukherjee S, Ndjomou J, Geiss BJ, Steel JJ, Frankowski KJ, Li K, Schoenen FJ, Frick DN.

ACS Infect Dis. 2015 Mar 13;1(3):140-148.

PMID:
26029739
2.

Clinical outcome and genetic differences within a monophyletic Dengue virus type 2 population.

Hapuarachchi HC, Chua RC, Shi Y, Thein TL, Lee LK, Lee KS, Lye DC, Ng LC, Leo YS.

PLoS One. 2015 Mar 26;10(3):e0121696. doi: 10.1371/journal.pone.0121696. eCollection 2015.

3.

The C-terminal 50 amino acid residues of dengue NS3 protein are important for NS3-NS5 interaction and viral replication.

Tay MY, Saw WG, Zhao Y, Chan KW, Singh D, Chong Y, Forwood JK, Ooi EE, Grüber G, Lescar J, Luo D, Vasudevan SG.

J Biol Chem. 2015 Jan 23;290(4):2379-94. doi: 10.1074/jbc.M114.607341. Epub 2014 Dec 8.

PMID:
25488659
4.

Structural models for the design of novel antiviral agents against Greek Goat Encephalitis.

Papageorgiou L, Loukatou S, Koumandou VL, Makałowski W, Megalooikonomou V, Vlachakis D, Kossida S.

PeerJ. 2014 Nov 6;2:e664. doi: 10.7717/peerj.664. eCollection 2014.

5.

Quantifying sequence and structural features of protein-RNA interactions.

Li S, Yamashita K, Amada KM, Standley DM.

Nucleic Acids Res. 2014 Sep;42(15):10086-98. doi: 10.1093/nar/gku681. Epub 2014 Jul 25.

6.

Host competence and helicase activity differences exhibited by West Nile viral variants expressing NS3-249 amino acid polymorphisms.

Langevin SA, Bowen RA, Reisen WK, Andrade CC, Ramey WN, Maharaj PD, Anishchenko M, Kenney JL, Duggal NK, Romo H, Bera AK, Sanders TA, Bosco-Lauth A, Smith JL, Kuhn R, Brault AC.

PLoS One. 2014 Jun 27;9(6):e100802. doi: 10.1371/journal.pone.0100802. eCollection 2014.

7.

Characterisation of divergent flavivirus NS3 and NS5 protein sequences detected in Rhipicephalus microplus ticks from Brazil.

Maruyama SR, Castro-Jorge LA, Ribeiro JM, Gardinassi LG, Garcia GR, Brandão LG, Rodrigues AR, Okada MI, Abrão EP, Ferreira BR, Fonseca BA, Miranda-Santos IK.

Mem Inst Oswaldo Cruz. 2014 Feb;109(1):38-50. doi: 10.1590/0074-0276130166. Epub 2013 Oct 10.

8.

Replication cycle and molecular biology of the West Nile virus.

Brinton MA.

Viruses. 2013 Dec 27;6(1):13-53. doi: 10.3390/v6010013. Review.

9.

Evolution and heterogeneity of multiple serotypes of Dengue virus in Pakistan, 2006-2011.

Koo C, Nasir A, Hapuarachchi HC, Lee KS, Hasan Z, Ng LC, Khan E.

Virol J. 2013 Sep 4;10:275. doi: 10.1186/1743-422X-10-275.

10.

Regulation of flavivirus RNA synthesis and capping.

Saeedi BJ, Geiss BJ.

Wiley Interdiscip Rev RNA. 2013 Nov-Dec;4(6):723-35. doi: 10.1002/wrna.1191. Epub 2013 Aug 8. Review.

11.
12.

Discovering new medicines targeting helicases: challenges and recent progress.

Shadrick WR, Ndjomou J, Kolli R, Mukherjee S, Hanson AM, Frick DN.

J Biomol Screen. 2013 Aug;18(7):761-81. doi: 10.1177/1087057113482586. Epub 2013 Mar 27. Review.

13.

Novel ATP-independent RNA annealing activity of the dengue virus NS3 helicase.

Gebhard LG, Kaufman SB, Gamarnik AV.

PLoS One. 2012;7(4):e36244. doi: 10.1371/journal.pone.0036244. Epub 2012 Apr 30.

14.

Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug.

Mastrangelo E, Pezzullo M, De Burghgraeve T, Kaptein S, Pastorino B, Dallmeier K, de Lamballerie X, Neyts J, Hanson AM, Frick DN, Bolognesi M, Milani M.

J Antimicrob Chemother. 2012 Aug;67(8):1884-94. doi: 10.1093/jac/dks147. Epub 2012 Apr 25.

15.

Analysis of RNA binding by the dengue virus NS5 RNA capping enzyme.

Henderson BR, Saeedi BJ, Campagnola G, Geiss BJ.

PLoS One. 2011;6(10):e25795. doi: 10.1371/journal.pone.0025795. Epub 2011 Oct 12.

16.

Nonconsensus West Nile virus genomes arising during mosquito infection suppress pathogenesis and modulate virus fitness in vivo.

Ebel GD, Fitzpatrick KA, Lim PY, Bennett CJ, Deardorff ER, Jerzak GV, Kramer LD, Zhou Y, Shi PY, Bernard KA.

J Virol. 2011 Dec;85(23):12605-13. doi: 10.1128/JVI.05637-11. Epub 2011 Sep 21.

17.

NS3 protease from flavivirus as a target for designing antiviral inhibitors against dengue virus.

Natarajan S.

Genet Mol Biol. 2010 Apr;33(2):214-9. doi: 10.1590/S1415-47572010000200002. Epub 2010 Jun 1.

18.

Functional analysis of two cavities in flavivirus NS5 polymerase.

Zou G, Chen YL, Dong H, Lim CC, Yap LJ, Yau YH, Shochat SG, Lescar J, Shi PY.

J Biol Chem. 2011 Apr 22;286(16):14362-72. doi: 10.1074/jbc.M110.214189. Epub 2011 Feb 23.

19.

Dimerization-driven interaction of hepatitis C virus core protein with NS3 helicase.

Mousseau G, Kota S, Takahashi V, Frick DN, Strosberg AD.

J Gen Virol. 2011 Jan;92(Pt 1):101-11. doi: 10.1099/vir.0.023325-0. Epub 2010 Sep 29.

20.

Prp43p contains a processive helicase structural architecture with a specific regulatory domain.

Walbott H, Mouffok S, Capeyrou R, Lebaron S, Humbert O, van Tilbeurgh H, Henry Y, Leulliot N.

EMBO J. 2010 Jul 7;29(13):2194-204. doi: 10.1038/emboj.2010.102. Epub 2010 May 28.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk